RxDoctor Payments DataLook up a doctor →

Jashin Wu

Dermatology · Corona, CANPI 1407953102

Payments from drug & device makers

$2,262,961in general payments, 2019–2025

Across 1,672 payments — averaging $1353.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$734K
  • Sun Pharmaceutical Industries Inc.$304K
  • Pfizer$233K
  • Amgen$140K
  • Bristol Myers Squibb$132K
  • Novartis$114K
  • plus $608K from 43 others
$46,024in research payments, 2019–2025

Across 46 payments — averaging $1000.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$11K
  • Regeneron$11K
  • Pfizer$10K
  • Novartis$9K
  • UCB, Inc.$2K
  • Sanofi$1K
  • plus $2K from 2 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,262,961 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Other dermatology in Corona

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →